Fort Sheridan Advisors’s Cellectis CLLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-15,300
Closed -$414K 165
2020
Q4
$414K Buy
+15,300
New +$343K 0.2% 70
2020
Q3
Sell
-12,197
Closed -$217K 114
2020
Q2
$217K Buy
+12,197
New +$186K 0.13% 91

Other funds holding CLLS

Fort Sheridan Advisors's CLLS Position: Q1 2021 in Review

Fort Sheridan Advisors sold out of Cellectis (CLLS) in Q1 2021, closing a stake of 15,300 shares — an estimated $414K sold.

Fort Sheridan Advisors first reported a position in CLLS in Q2 2020 and held it in 2 quarters. The position peaked at $414K in Q4 2020. 81 funds tracked by Wall St. Rank hold CLLS as of Q1 2021.

  • Fort Sheridan Advisors reported no remaining Cellectis position as of Q1 2021 after selling out during the quarter.
  • Fort Sheridan Advisors sold 15,300 Cellectis shares in Q1 2021, an estimated $414K.
  • Fort Sheridan Advisors first reported a position in Cellectis in Q2 2020 and held it in 2 quarters.
  • Fort Sheridan Advisors's Cellectis position peaked at $414K in Q4 2020.
  • 81 funds tracked by Wall St. Rank held Cellectis as of Q1 2021.

Based on Fort Sheridan Advisors's 13F filing for Q1 2021, filed 17 May 2021.